Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2012
03/14/2012CN102370646A Substance for protecting heart
03/14/2012CN102370644A Nifedipine medicine composition and preparation method thereof
03/14/2012CN102370637A Application of atorvastatin in preparation of drug for promoting mesenhymal stem cell surviving in vivo and mesenhymal stem cell differentiation into myocardial cells
03/14/2012CN102370636A Application of simvastatin for promoting bone marrow-derived mesenchymal stem cell survival and differentiation towards cardiomyocyte
03/14/2012CN102370628A Tetra-acetylated puerarin self-microemulsified sustained-release double-layer tablet and preparation method thereof
03/14/2012CN102370625A Felodipine tablets
03/14/2012CN102370620A Pulmonic targeting immuno nano liposome and preparation method thereof
03/14/2012CN102370396A Healthcare pillow
03/14/2012CN102370395A Chinese medicinal health-care pillow and manufacturing method thereof
03/14/2012CN102370251A Preparing technique of health-care underwear
03/14/2012CN102370250A Health-care underwear
03/14/2012CN101978987B Application of herba rabdosiae rubescentis extract to preparation of medicament for treating and resisting cerebral ischemia
03/14/2012CN101926869B Medicament for treating dizziness and headache and preparation method thereof
03/14/2012CN101745028B Drug for treatment of diabetes and complications thereof and preparation method thereof
03/14/2012CN101711793B Medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof
03/14/2012CN101703494B Transdermal nitrendipine adhesive patch and preparation method thereof
03/14/2012CN101564388B Composition for Danshensu and danshinolic acid B and use thereof
03/14/2012CN101528687B Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same
03/14/2012CN101513512B Drug for cardiac care and coronary heart disease treatment
03/14/2012CN101422595B Traditional Chinese medicine composition for treating dizziness and preparation method and quality control method thereof
03/14/2012CN101313982B Traditional Chinese medicine onion slurry, preparing method and uses thereof
03/14/2012CN101306129B Chinese herbal medicine compound preparation for treating hypertension and its preparation method
03/14/2012CN101233225B Strain of turkey tail mushroom, extract from the same, and use of the same
03/14/2012CN101121003B Vinegar with disease treating function and manufacturing method thereof
03/14/2012CN101096359B Polyaryl substituted methane oxygen or silica radical guanidine compound and preparation method and usage thereof
03/14/2012CN101039585B Mixture of phytosterol ester(s) and 1,3-diglyceride(s) for use in the treatment of medical conditions
03/13/2012USRE43244 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
03/13/2012US8133992 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
03/13/2012US8133878 Methods for treating restenosis
03/13/2012US8133877 Composition comprising an antisense sequence implicated in the regulation of angiogenesis
03/13/2012CA2515574C Aminophosphonic acid derivative, salt thereof, and modulator of s1p receptor
03/13/2012CA2486539C C-aryl glucoside sglt2 inhibitors and method
03/13/2012CA2467159C Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
03/13/2012CA2442854C Hsa-free formulations of interferon-beta
03/13/2012CA2369074C Ether compounds, compositions, and uses thereof
03/08/2012WO2012030745A1 MULTIVITAMIN TARGETING OF RNAi THERAPEUTICS
03/08/2012WO2012030394A1 Treatment of myocardial infarction using tgf - beta antagonists
03/08/2012WO2012029942A1 Cyclic amide derivative
03/08/2012WO2012029722A1 Screening method
03/08/2012WO2012029529A1 Eggshell membrane solubilization method using enzymes
03/08/2012WO2012028966A2 Combination dosage compositions comprising a cholesterol-lowering agent, a renin-angiotensin system inhibitor, an antioxidant agent and an antiplatelet agent for treatment and prevention of cardiovascular disease
03/08/2012WO2012028647A1 Bicyclic aza heterocycles, and use thereof
03/08/2012WO2012028644A1 Substituted n-phenethyltriazoloneacetamides and use thereof
03/08/2012WO2012028311A1 Compositions comprising a taxane for coating medical devices
03/08/2012WO2012028056A1 A clinical preparation of scutellarin and the preparation method thereof
03/08/2012WO2012027968A1 Panaxatriol saponins enteric pellet, capsule comprising same and method for preparing same
03/08/2012WO2011153226A3 Cellular constituents from bacteroides, compositions thereof, and therapeutic methods employing bacteroides or cellular constituents thereof
03/08/2012WO2011133875A3 Metalloenzyme inhibitor compounds
03/08/2012WO2011133696A3 Methods of suppressing atherosclerosis
03/08/2012WO2011130740A3 Pyridylthiazole-based ureas as inhibitors of rho associated protein kinase (rock) and methods of use
03/08/2012WO2011130537A3 Pharmaceutical compositions and methods for digesting atherosclerotic plaques
03/08/2012WO2011126264A3 Method for increasing activity in human stem cell
03/08/2012WO2011122805A3 A composition comprising ajoene for preventing or treating a disease caused by overexpression of lxr-alpha
03/08/2012WO2003032894A3 Method of monitoring neuroprotective treatment
03/08/2012US20120059176 Anti-inflammatory modalities
03/08/2012US20120059064 Compositions and Methods For Inhibiting an Isoform of Human Manganese Superoxide Dismutase
03/08/2012US20120059061 Novel anti-inflammatory compounds
03/08/2012US20120059052 Prenylflavonoid formulations
03/08/2012US20120059046 Inhibition of map4k4 through rnai
03/08/2012US20120059044 Methods of utilizing the arrestin-2/stam-1 complex as a therapeutic target
03/08/2012US20120059039 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
03/08/2012US20120059022 Crystalline Form of Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoicacid] Calcium Salt
03/08/2012US20120059016 Piperidine and piperazine derivatives as autotaxin inhibitors
03/08/2012US20120059014 Compounds for the Treatment of Metabolic Disorders
03/08/2012US20120059012 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
03/08/2012US20120059007 Pharmacologically-active vanilloid carbamates
03/08/2012US20120059006 Sigma receptor inhibitors
03/08/2012US20120059002 Novel anti-inflammatory agents
03/08/2012US20120059001 Novel kinase modulators
03/08/2012US20120058999 Substituted Tetrahydropyrrolopyrazine Compounds
03/08/2012US20120058990 Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
03/08/2012US20120058981 Androgen pharmaceutical composition and method for treating depression
03/08/2012US20120058975 Phosphonate Compounds
03/08/2012US20120058972 Novel use
03/08/2012US20120058967 Vascular protecting agent having salt-absorption inhibitory activity
03/08/2012US20120058966 Sphingosine Kinase Inhibitor Prodrugs
03/08/2012US20120058965 Methods and systems for modulating hormones and related methods, agents and compositions
03/08/2012US20120058957 Compositions and methods for counteracting effects of reactive oxygen species and free radicals
03/08/2012US20120058947 Prophylactic agent for heart failure
03/08/2012US20120058946 Compound and method for treating myotonic dystrophy
03/08/2012US20120058941 Glucopyranoside compound
03/08/2012US20120058938 Nutritional composition inducing a postprandial endocrine response
03/08/2012US20120058934 Treatment of diseases
03/08/2012US20120058207 Anti-diabetic nutraceutical composition from palm leaf extract
03/08/2012US20120058201 Method of predicting a predisposition to qt prolongation
03/08/2012US20120058175 Transdermal Preparation
03/08/2012US20120058160 Particulate materials
03/08/2012US20120058157 Methods of Treating Cardiovascular Disorders Associated with Atherosclerosis
03/08/2012US20120058151 nanoparticulate compositions of poorly soluble compounds
03/08/2012US20120058137 Efficient transport into white blood cells
03/08/2012US20120058132 Treatment of glycogen storage disease type II
03/08/2012US20120058128 Anti- integrin antibodies, compositions, methods and uses
03/08/2012US20120058125 Methods relating to peripheral administration of nogo receptor polypeptides
03/08/2012US20120058120 Targets for Growth Factor Signalling and Methods of Therapy
03/08/2012US20120058107 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
03/08/2012US20120058102 Pharmacologically induced transgene ablation system
03/08/2012US20120058100 Modulation of drug release rate from electrospun fibers
03/08/2012US20120058094 Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
03/08/2012US20120058093 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
03/08/2012US20120058089 Treatment of organ injuries and burns using placental stem cells
1 ... 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 ... 1595